» Articles » PMID: 23238640

Eosinophils Mediate the Pathogenesis of Halothane-induced Liver Injury in Mice

Overview
Journal Hepatology
Specialty Gastroenterology
Date 2012 Dec 15
PMID 23238640
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Drug-induced liver injury (DILI) is a major health issue, as it remains difficult to predict which new drugs will cause injury and who will be susceptible to this disease. This is due in part to the lack of animal models and knowledge of susceptibility factors that predispose individuals to DILI. In this regard, liver eosinophilia has often been associated with DILI, although its role remains unclear. We decided to investigate this problem in a murine model of halothane-induced liver injury (HILI). When female Balb/cJ mice were administered halothane, eosinophils were detected by flow cytometry in the liver within 12 hours and increased thereafter proportionally to liver damage. Chemokines, eotaxin-1 (CCL11) and eotaxin-2 (CCL24), which are known to attract eosinophils, increased in response to halothane treatment. The severity of HILI was decreased significantly when the study was repeated in wildtype mice made deficient in eosinophils with a depleting antibody and in eosinophil lineage-ablated ΔdblGata(-/-) mice. Moreover, depletion of neutrophils by pretreating animals with Gr-1 antibody prior to halothane administration failed to reduce the severity of HILI at antibody concentrations that did not affect hepatic eosinophils. Immunohistochemical staining for the granule protein, major basic protein, revealed that eosinophils accumulated exclusively around areas of hepatocellular necrosis.

Conclusion: Our findings indicate that eosinophils have a pathologic role in HILI in mice and suggest that they may contribute similarly in many clinical cases of DILI.

Citing Articles

Innate immune regulation in inflammation resolution and liver regeneration in drug-induced liver injury.

Qian Y, Zhao J, Wu H, Kong X Arch Toxicol. 2024; 99(1):115-126.

PMID: 39395921 DOI: 10.1007/s00204-024-03886-0.


The Role of Eosinophils in Liver Disease.

Xie L, Zhang H, Xu L Cell Mol Gastroenterol Hepatol. 2024; 19(2):101413.

PMID: 39349246 PMC: 11719855. DOI: 10.1016/j.jcmgh.2024.101413.


Nanotherapeutics for Alleviating Anesthesia-Associated Complications.

Lu B, Wei L, Shi G, Du J Adv Sci (Weinh). 2024; 11(15):e2308241.

PMID: 38342603 PMC: 11022745. DOI: 10.1002/advs.202308241.


Hybrid Endometrial-Derived Hydrogels: Human Organoid Culture Models and In Vivo Perspectives.

Gomez-Alvarez M, Bueno-Fernandez C, Rodriguez-Eguren A, Frances-Herrero E, Agustina-Hernandez M, Faus A Adv Healthc Mater. 2023; 13(11):e2303838.

PMID: 37983675 PMC: 11468130. DOI: 10.1002/adhm.202303838.


C-C motif chemokine CCL11 is a novel regulator and a potential therapeutic target in non-alcoholic fatty liver disease.

Fan Z, Sun X, Chen X, Liu H, Miao X, Guo Y JHEP Rep. 2023; 5(9):100805.

PMID: 37555008 PMC: 10404559. DOI: 10.1016/j.jhepr.2023.100805.


References
1.
Aithal G, Ramsay L, Daly A, Sonchit N, Leathart J, Alexander G . Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity. Hepatology. 2004; 39(5):1430-40. DOI: 10.1002/hep.20205. View

2.
Louis H, Le Moine A, Flamand V, Nagy N, Quertinmont E, Paulart F . Critical role of interleukin 5 and eosinophils in concanavalin A-induced hepatitis in mice. Gastroenterology. 2002; 122(7):2001-10. DOI: 10.1053/gast.2002.33620. View

3.
Pham B, Bemuau J, Durand F, Sauvanet A, Degott C, Prin L . Eotaxin expression and eosinophil infiltrate in the liver of patients with drug-induced liver disease. J Hepatol. 2001; 34(4):537-47. DOI: 10.1016/s0168-8278(00)00057-x. View

4.
Dyer K, Garcia-Crespo K, Killoran K, Rosenberg H . Antigen profiles for the quantitative assessment of eosinophils in mouse tissues by flow cytometry. J Immunol Methods. 2011; 369(1-2):91-7. PMC: 3116057. DOI: 10.1016/j.jim.2011.04.009. View

5.
Feng D, Wang Y, Xu Y, Luo Q, Lan B, Xu L . Interleukin 10 deficiency exacerbates halothane induced liver injury by increasing interleukin 8 expression and neutrophil infiltration. Biochem Pharmacol. 2008; 77(2):277-84. DOI: 10.1016/j.bcp.2008.09.028. View